Home Celularity

Celularity

acquired
Post-IPO Round
Cellular Medicine Biotechnology R&D Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

Celularity's innovative approach to cell therapy leverages the unique therapeutic potential locked within postpartum placental cells. We have multiple cell therapy candidates in preclinical and clinical development, as well as placenta-derived products for surgical use.
Celularity, Inc.
NewJersey,United States of America
101~500 people
January 01, 2016
Contact Email media@celularity.com

Enterprise Profile

Industrial Sector
New Drug Development Production of Genetically Engineered Drugs
Technology
Gene Technology Cell Technology
Concept
Therapeutic Products Gastric Cancer Esophageal Cancer
Application Scenarios
Biologics Innovative Drugs Novel Coronavirus